Inferior Vena Cava Filters (IVCF) Pipeline Report 2024: Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies [Yahoo! Finance]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Yahoo! Finance
and Countries, Regulatory Path and Key Companies, 2024 Update" report has been added to ResearchAndMarkets.com's offering. This report provides comprehensive information about the Inferior Vena Cava Filters (IVCF) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Inferior Vena Cava Filter (IVCF) is a metallic device used to prevent blood clots from traveling to lungs. The filter is inserted inside a large vein called the inferior vena cava (which carries blood from lower extremities to the heart). IVC filter traps blood clots before it reaches to the lungs. Scope Extensive coverage of the Inferior Vena Cava Filters (IVCF) under development The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities The report reviews the major players involved in the development of I
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- Specimen Retrieval Global Strategic Research Report 2024: Market to Reach $408.4 Million by 2030 - Prevalence of Lifestyle-Related Chronic Disorders Continues to Rise, Presenting Market Opportunities [Yahoo! Finance]Yahoo! Finance
- Implicity Earns FDA Clearance for New Heart Failure Prediction Algorithm [Yahoo! Finance]Yahoo! Finance
- Levi & Korsinsky, LLP Notifies Shareholders of Boston Scientific Corporation (BSX) an Upcoming Claims Deadline in a Class Action SettlementAccesswire
- Peripheral Artery Disease Market to Reach $10.8 billion, Globally, by 2035 at 7.7% CAGR: Allied Market Research [Yahoo! Finance]Yahoo! Finance
- NICE recommends targeted radiation therapy for liver tumours [Yahoo! Finance]Yahoo! Finance
BSX
Earnings
- 4/24/24 - Miss
BSX
Sec Filings
- 5/14/24 - Form 4
- 5/13/24 - Form 4
- 5/13/24 - Form 4
- BSX's page on the SEC website